Yu Yao

The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer

Yongkang Liao, Shusha Yin, E-ying Peng, Jinjie Wu et autres

cn (code pays fourni par la source)

Updated clinical practice guidelines for the management of adult diffuse gliomas

Do‐Hyun Nam, Zvi Ram, Wai-Sang Poo, Jiguang Wang et autres

cn, kr, il, hk, mn, sg, ru (code pays fourni par la source)

Multi-omics profiling reveals organ-specific anti-inflammatory metabolites and biosynthetic regulation in Lindera aggregata taproot-bark

Yu Yao, Li Lu, Ningxi Song, Zhi‐Yuan Hu et autres

cn (code pays fourni par la source)

Mechanisms of the Ershiwuwei Guijiu Pill in Treating Postmenopausal Osteoporosis Based on Network Analysis and Experimental Validation

Lixue Zhang, Muhammad Naveed, Peifeng Wu, Yu Yao et autres

cn, us, pk (code pays fourni par la source)

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial

Di Chen, Zhenyu Zhang, Ying Qi, Dikang Chen et autres

cn (code pays fourni par la source)

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuankai Shi, Jian Fang, Ligang Xing, Yu Yao et autres

cn (code pays fourni par la source)

Comparative Analysis of Y-Chromosome Data from Xinjiang and Ningxia Hui Populations with the Hui Population Nationwide

Xin Chang, Yini Yang, Yu Yao, Jianxue Xiong et autres

Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy

Jinsen Zhang, Rui Sun, Yingying Lyu, Chaxian Liu et autres

cn, us, hu (code pays fourni par la source)

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy

Xuefen Zhuang, Shusha Yin, Cheng Ji, Wenshuang Sun et autres

cn (code pays fourni par la source)

Neutrophil Extracellular Traps Regulate the Pathogenesis of Pulmonary Fibrosis by Inducing Epithelial-Mesenchymal Transition

Wenchao Shi, Yu Shang, Zhiheng Li, Yu Yao et autres

cn (code pays fourni par la source)

PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)

Jinming Yu, Xue Meng, Haiyan Ge, Qing Liu et autres

cn, us (code pays fourni par la source)

TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma

Qinghong Li, Kunming Zhang, Yu Yao, Zeng Yu et autres

cn (code pays fourni par la source)